Optimize Low Back Pain
Status: | Not yet recruiting |
---|---|
Conditions: | Back Pain, Back Pain, Chronic Pain, Chronic Pain |
Therapuetic Areas: | Musculoskeletal |
Healthy: | No |
Age Range: | 18 - 64 |
Updated: | 3/3/2019 |
Start Date: | April 1, 2019 |
End Date: | August 1, 2023 |
Contact: | Elizabeth Lane, PT, DPT |
Email: | Elizabeth.Lane@hsc.utah.edu |
Phone: | 801-581-6861 |
Optimized Multidisciplinary Treatment Programs for Nonspecific Chronic Low Back Pain
The objective of this study is to improve health care for patients with chronic LBP and
increase the likelihood that patients obtain outcomes that matter most to them. The
investigators will accomplish our goal using a sequential multiple randomization (SMART)
design comparing the effectiveness of Phase 1 (PT v. CBT) treatments for patients with
chronic LBP; and among patient non-responsive to Phase I treatment, compare the effectiveness
of Phase II treatments (switching to PT or CBT v. mindfulness). Effectiveness will be based
on patient-centered outcomes. Sub-aims will compare main effects of Phase 1 and 2 treatment
options and the sequencing effects of different treatment combinations.
increase the likelihood that patients obtain outcomes that matter most to them. The
investigators will accomplish our goal using a sequential multiple randomization (SMART)
design comparing the effectiveness of Phase 1 (PT v. CBT) treatments for patients with
chronic LBP; and among patient non-responsive to Phase I treatment, compare the effectiveness
of Phase II treatments (switching to PT or CBT v. mindfulness). Effectiveness will be based
on patient-centered outcomes. Sub-aims will compare main effects of Phase 1 and 2 treatment
options and the sequencing effects of different treatment combinations.
The study uses a sequential multiple randomization (SMART) design. The study will compare the
effectiveness of common first-line treatments for chronic LBP: PT or CBT. Initial treatment
will be 8 weeks duration with re-evaluation at 10-weeks after enrollment to allow time to
complete treatment. At the 10-week assessment researchers will examine if the patient has
responded to initial treatment using a patient-centered, validated definition of successful
response based on 50% improvement in the Oswestry Disability Index (ODI). Patients who are
responders to initial treatment will receive up to 2 additional sessions of the same
treatment to assist transition to self-management. Non-responders will be re-randomized to a
second treatment strategy of either switching to the other initial treatment (i.e., patients
receiving PT switch to CBT or vice versa), or mindfulness. The second treatment phase is also
8 weeks in duration. Additional follow-ups occur 26- and 52 weeks after enrollment.
The study has two co-primary outcomes; function and pain. The investigators will use the ODI,
a well-validated, reliable and responsive patient-reported measure of LBP-related function
recommended by the NIH Back Pain Task Force. The investigators will assess pain intensity
with 0-10 ratings ('0' indicating no pain and '10' worst imaginable pain). Separate ratings
are made for current, worst and best pain over the past 24 hours with an average computed to
represent pain intensity. Secondary outcomes will assess dimensions of quality of life, work
and healthcare utilization.
effectiveness of common first-line treatments for chronic LBP: PT or CBT. Initial treatment
will be 8 weeks duration with re-evaluation at 10-weeks after enrollment to allow time to
complete treatment. At the 10-week assessment researchers will examine if the patient has
responded to initial treatment using a patient-centered, validated definition of successful
response based on 50% improvement in the Oswestry Disability Index (ODI). Patients who are
responders to initial treatment will receive up to 2 additional sessions of the same
treatment to assist transition to self-management. Non-responders will be re-randomized to a
second treatment strategy of either switching to the other initial treatment (i.e., patients
receiving PT switch to CBT or vice versa), or mindfulness. The second treatment phase is also
8 weeks in duration. Additional follow-ups occur 26- and 52 weeks after enrollment.
The study has two co-primary outcomes; function and pain. The investigators will use the ODI,
a well-validated, reliable and responsive patient-reported measure of LBP-related function
recommended by the NIH Back Pain Task Force. The investigators will assess pain intensity
with 0-10 ratings ('0' indicating no pain and '10' worst imaginable pain). Separate ratings
are made for current, worst and best pain over the past 24 hours with an average computed to
represent pain intensity. Secondary outcomes will assess dimensions of quality of life, work
and healthcare utilization.
Inclusion Criteria:
- Age 18 - 64 years at the time of enrollment.
- Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has
LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing
problem for you over the past 6 months? A response of greater than 3 months to
question 1, and "at least half the days in the past 6 months" to question 2 is
required to satisfy the NIH definition of chronic LBP.
- Healthcare visit for LBP in the past 90 days.
- At least moderate levels of pain and disability requiring ODI score >24 and pain
intensity rating > 4.
Exclusion Criteria:
- Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory
disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
- Evidence of a specific spinal pathology as the cause of LBP including spine fracture,
spinal stenosis, radiculopathy, etc.
- Knowingly pregnant
- Has received physical therapy for LBP; or CBT or mindfulness for any reason with a
provider in prior 90 days
- Currently receiving substance use disorder treatment
- Any lumbar spine surgery in the past year.
We found this trial at
3
sites
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
Baltimore, Maryland 21205
410-516-8000
Principal Investigator: Richard Skolasky, ScD
Phone: 410-502-4453
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
Click here to add this to my saved trials